Marine Drugs Receives an Increased CiteScore of 10.1

We are pleased to share that Marine Drugs (ISSN: 1660-3397) has received an increased CiteScore of 10.1 in June 2025. The CiteScore ranks Q1 in all categories: 4 out of 46 titles in the “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)” category, 20 out of 185 titles in the “Pharmaceutical Science” category, and 24 out of 156 titles in the “Drug Discovery” category. 

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance. 

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Marine Drugs and its growing impact in the research, development, and production of biologically and therapeutically active compounds from the sea.